URGNUroGen Pharma Ltd. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 23083
Ticker: URGN
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2017-05-04
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: URGN

Detail

Enriched 2026-08-14 20:47

Market cap: $2,387,363,349
Shares outstanding (class): 48,880,564
Shares outstanding (weighted): 48,721,701
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 291
Location: RA'ANANA, L3
Homepage: https://www.urogen.com
Description: UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Market cap and share counts drift.

Funds holding this security

68 funds · 68 positions · $46.98M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Russell 2000 ETF iShares Trust	IWM	$17.58M	0.02%	977,491 NS	TICKER
iShares Biotechnology ETF iShares Trust	IBB	$5.14M	0.06%	286,041 NS	TICKER
iShares Russell 2000 Growth ETF iShares Trust	IWO	$4.86M	0.04%	270,225 NS	TICKER
State Street(R) SPDR(R) Portfolio Developed Wor… SPDR INDEX SHARES FUNDS	SPDW	$3.32M	0.01%	184,862 NS	TICKER
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$2.22M	0.05%	123,301 NS	TICKER
iShares Micro-Cap ETF iShares Trust	IWC	$1.82M	0.15%	101,436 NS	TICKER
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.12M	0.02%	62,333 NS	TICKER
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.12M	0.01%	62,256 NS	TICKER
Clearwater Select Equity Fund Clearwater Investment Trust	—	$1.10M	0.25%	61,274 NS	TICKER
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$777.1K	0.02%	43,218 NS	TICKER
M Capital Appreciation Fund M FUND INC	—	$669.2K	0.25%	37,221 NS	TICKER
Amplify BlueStar Israel Technology ETF Amplify ETF Trust	—	$541.1K	0.51%	30,097 NS	TICKER
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$453.1K	0.02%	25,200 NS	TICKER
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$452.8K	0.04%	25,184 NS	TICKER
VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II	—	$350.9K	0.07%	19,515 NS	TICKER

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

This match is a candidate, not a mapping. N-PORT tickers are filer-entered free text and collide with delisted and foreign symbols. Only 13% of positions carry a ticker at all. Good enough to ask which funds report holding a symbol; not good enough to build exposure reporting on. Prefer the ISIN-resolved link, which is marked FIGI_COMPOSITE.

Funds holding this security

Identifiers

master.security_identifier

TICKERURGN
CIK0001668243
ISINIL0011407140
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: UroGen Pharma is a biopharmaceutical company developing treatments for urological cancers, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.